Genitourinary tract symptoms in patients admitted with COVID-19: Exploring changes in frequency by determinants and pandemic waves

Urothelial cells exhibit increased expression of angiotensin-converting enzyme-2 receptor, which is the binding site of severe acute respiratory syndrome coronavirus 2 to cells. The frequency and distribution of genitourinary tract symptoms in patients diagnosed with coronavirus disease 2019 (COVID-...

Full description

Saved in:

Bibliographic Details
Published in:	Continence (Amsterdam) Vol. 5; p. 100572
Main Authors:	Viegas Madrid, Vanessa, Peláez Laderas, Adrián, Soriano, Joan B., Girón Moreno, Rosa, Marcos, Maria Celeste, Sánchez Ramírez, Ana, Bermúdez, Julio Ancochea, Olivier Gómez, Carlos, López-Fando Lavalle, Luis
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01-03-2023 The Author(s). Published by Elsevier B.V. on behalf of International Continence Society Elsevier
Subjects:	Acute kidney injury Acute urinary retention COVID-19 Genitourinary tract symptoms Pandemic waves Urinary incontinence Urinary tract infections COVID-19 Urinary incontinence Acute urinary retention Genitourinary tract symptoms Pandemic waves Acute kidney injury Urinary tract infections
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Urothelial cells exhibit increased expression of angiotensin-converting enzyme-2 receptor, which is the binding site of severe acute respiratory syndrome coronavirus 2 to cells. The frequency and distribution of genitourinary tract symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19) is unknown. We explored trends in genitourinary tract symptoms by gender and each of six pandemic waves in patients admitted for COVID-19, and related them with severity, death and length of hospitalization. A retrospective study took place in our institution of COVID-19 admitted patients. Only patients with RT-PCR or antigen test confirmed SARS-CoV-2 infection were included. Demographic, clinical, and genitourinary symptoms were explored. COVID-19 patients with genitourinary tract symptoms were compared with those without. Statistical comparisons were conducted by parametric and nonparametric tests for quantitative variables, and χ2 test for qualitative variables. Out of a total of 4,661 COVID-19 patients, genitourinary symptoms were found in 21,1%. These symptoms were more frequent in patients admitted for longer than 30 days, except for urinary incontinence (UI) and erectile dysfunction (ED). Acute kidney injury (AKI) and urinary tract infections (UTI) had a higher presence in the 5th (16.7%; 12.8% respectively) and 3rd wave (13.3%; 12.6% respectively). Genitourinary symptoms were higher for those patients admitted in critical care units. Frequency of AKI, UI, UTI and acute urinary retention (AUR) were higher for patients who were finally deceased (26.2%; 3.5%; 13.6% and 3.6% respectively). A high frequency of genitourinary symptoms in patients admitted for COVID-19 was observed, whose frequency and distribution varied according to pandemic waves. Specific genitourinary conditions were associated with worse outcomes and poorer prognosis. •Genitourinary tract symptoms are frequent in COVID-19 hospitalized patients.•Genitourinary tract symptoms in COVID patients were associated with worse outcomes and poorer prognosis.•COVID-19 patients with genitourinary tract symptoms were related with worse prognosis in all pandemic waves.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Mailing adress: Calle César Manrique 16, Torrejón de Ardoz, Madrid. CP 28850.
ISSN:	2772-9737 2772-9737
DOI:	10.1016/j.cont.2022.100572